Public Profile

HYBIO

HYBIO, officially known as Hubei Biocause Pharmaceutical Co., Ltd., is a prominent player in the biopharmaceutical industry, headquartered in China. Founded in 2001, the company has established itself as a leader in the development and production of high-quality biological products, particularly in the fields of vaccines and diagnostic reagents. With a strong operational presence across various regions in China, HYBIO has achieved significant milestones, including the successful launch of innovative vaccine solutions that cater to both human and animal health. Their core offerings are distinguished by advanced technology and rigorous quality control, ensuring efficacy and safety. Recognised for its commitment to research and development, HYBIO has garnered a solid market position, contributing to the advancement of healthcare solutions in the biopharmaceutical sector.

DitchCarbon Score

How does HYBIO's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

HYBIO's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

HYBIO's reported carbon emissions

HYBIO, headquartered in China (CN), currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action. In the absence of detailed emissions data, it is essential for HYBIO to establish clear climate commitments and reduction initiatives to align with industry standards and expectations for sustainability.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. HYBIO's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. HYBIO is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

HYBIO is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Care Shop Ltd

GB
Health Services
Updated 4 days ago

The Wilf Ward Family Trust

GB
Health Services
Updated 10 days ago

Meggle

AE
Health Services
Updated 10 days ago

AROBS

RO
Health Services
Updated 10 days ago

Colisee

FR
Health Services
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers